These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4787779)

  • 1. [Pyridoxine para-chloro-phenoxy-isobutyrate. Analysis of hypolipidemic effects].
    Mirouze J; Orsetti A; Cartry E
    Nouv Presse Med; 1973 Dec; 2(46):3115-6. PubMed ID: 4787779
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical and biological study of a new vascular protective agent and hypolipemic agent, pyridoxine para-chloro-phénoxy-isobutyrate. (Claresan)].
    Fourrier A; Mouton Y
    Lille Med; 1974 Apr; 19(4 Suppl 11):532-7. PubMed ID: 4612283
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of hyperlipidemias. Value of a new hypolipidemic drug clofibride, (M-G. 46)].
    Leutenegger M; Choisy H; Caron J; Paris H
    Therapie; 1974; 29(4):599-610. PubMed ID: 4439371
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antilipidemic activity of ethyl-chloro-phenoxy-isobutyrate or clofibrate].
    Barisone D; Gallo G; Accardo S
    Minerva Med; 1969 Jan; 60(6):174-80. PubMed ID: 5776766
    [No Abstract]   [Full Text] [Related]  

  • 5. [Interference of clofibrate in metabolic compensation in dyslipidemic diabetics].
    Gatti A; Carletta C
    Clin Ter; 1979 Oct; 91(1):57-65. PubMed ID: 397871
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative evaluation of beta-benzalbutyramide and clofibrate in the short-term treatment of hyperlipidemic patients].
    Marini U; Bargiggia A; Riboli P
    Farmaco Prat; 1981 Dec; 36(12):532-41. PubMed ID: 7319020
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical trial of C.P.I.B. (clofibrate) in treatment of diabetic hypertriglyceridemia].
    Warembourg H; Jaillard J
    Lille Med; 1968 Jan; 13(1):Suppl:5-8. PubMed ID: 5745605
    [No Abstract]   [Full Text] [Related]  

  • 8. Diet and drugs in the treatment of hyperlipidemias.
    Med Lett Drugs Ther; 1970 May; 12(10):42-4. PubMed ID: 5514225
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hypolipemic effectiveness of using miskleron in diabetes mellitus in children and adolescents with lipodystrophies].
    Belousova LV
    Pediatriia; 1980 Jun; (6):39-41. PubMed ID: 7402836
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical experimentation of clofibride. Apropos of 40 cases].
    Warembourg H; Jaillard J
    Lille Med; 1973 Dec; 18(10 Suppl 5):suppl 5:1292-6. PubMed ID: 4802928
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical experimentation with RU 19,(83 (Dabical) calcium clofibrate].
    Pauchant M; Bourbillon JP
    Lille Med; 1976 Jan; 21(1 suppl 1):24-8. PubMed ID: 1256229
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hypolipidemic efficacy of clofibrate preparations (atromid C, atromidine, mixleron) in coronary atherosclerosis with different types of hyperlipoproteinemia].
    Zakharov VN
    Ter Arkh; 1977; 49(4):111-3. PubMed ID: 867253
    [No Abstract]   [Full Text] [Related]  

  • 13. High death rate from neoplasms in French diabetic and non-diabetic men.
    Balkau B; Charles MA; Eschwège E
    Lancet; 1998 May; 351(9114):1512. PubMed ID: 9605828
    [No Abstract]   [Full Text] [Related]  

  • 14. [Study of clofibrate. The opinion of Prof. D. Kritchevsky].
    Fabbrocini V
    Minerva Cardioangiol; 1980 Nov; 28(11):759-60. PubMed ID: 7231692
    [No Abstract]   [Full Text] [Related]  

  • 15. Clofibrate.
    Downie CC
    Lancet; 1979 Feb; 1(8111):318. PubMed ID: 84964
    [No Abstract]   [Full Text] [Related]  

  • 16. Clofibrate.
    Lancet; 1978 Dec; 2(8103):1302-3. PubMed ID: 82797
    [No Abstract]   [Full Text] [Related]  

  • 17. [The question of adverse effects of clofibrate. Experience in patients with diabetes mellitus].
    Häser C; Rahlfs V; Mehnert H
    Ther Ggw; 1976 Aug; 115(8):1382-95. PubMed ID: 793084
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clofibrate in diabetes insipidus (author's transl)].
    Oster P; Raetzer H; Schlierf G
    Dtsch Med Wochenschr; 1974 Jul; 99(30):1564-5. PubMed ID: 4367876
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hypolipidemic action of simfibrate in diabetic subjects].
    Gragnoli G; Tanganelli I; Signorini AM; Kristodhullu A
    Clin Ter; 1981 Feb; 96(4):397-408. PubMed ID: 7214862
    [No Abstract]   [Full Text] [Related]  

  • 20. [Lipid metabolism disorders and deafness of the inner ear. Therapeutic approaches: clinical testing of clofibrate (Lipavlon: I.C.I. Pharma laboratories)].
    Martin PH; Oudot J
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1977 Nov; 26(9):725-8. PubMed ID: 146069
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.